Total revenue from continuing operations increased 7%; constant currency organic revenue grew 7%As reported diluted EPS from continuing operations increased to $1.51; adjusted EPS increased to $2.14Fiscal 2025 outlook reiterated DUBLIN, IRELAND, Nov. 06, 2024 (GLOBE NEWSWIRE) --  - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 second quarter ended September 30, 2024. Total revenue from continuing operations for the second quarter of fiscal 2025 inc ...